Metabolic acidosis due to organic acids infusion fails to elicit hyperkalemia. Although plasma potassium levels may rise, the increase is smaller than in mineral acid acidosis. The mechanisms responsible for the different effects of organic acid acidosis and mineral acid acidosis remain undefined, although dissimilar hormonal responses by the pancreas may explain dissimilar hormonal responses by the pancreas may explain the phenomena. To test this hypothesis, beta-hydroxybutyric acid (7 meq/kg) or hydrochloric acid (3 meq/kg) was infused over 30 min into conscious dogs (n = 12) with chronically implanted catheters in the portal, hepatic, and systemic circulation, and flow probes were placed around the portal vein and hepatic artery. Acid infusion studies in two groups of anesthetized dogs were also done to assess the urinary excretion of potassium (n = 14), and to evaluate the effects of acute suppression of renal electrolyte excretion on plasma potassium and on the release/uptake of potassium in peripheral tissues of the hindleg (n = 17). Ketoacid infusion caused hypokalemia and a significant increase in portal vein plasma insulin, from the basal level of 27 +/- 4 microU/ml to a maximum of 84 +/- 22 microU/ml at 10 min, without changes in glucagon levels. By contrast, mineral acid acidosis of similar severity resulted in hyperkalemia and did not increase portal insulin levels but enhanced portal glucagon concentration from control values of 132 +/- 25 pg/ml to 251 +/- 39 pg/ml at 40 min. A significant decrease in plasma glucose levels due to suppression of hepatic release was observed during ketoacid infusion, while no changes were observed with mineral acid infusion. Plasma flows in the portal vein and hepatic artery remained unchanged from control values in both acid infusion studies. Differences in renal potassium excretion were ruled out as determinants of the disparate kalemic responses to organic acid infusion compared with HCl acidosis. Evaluation of the arteriovenous potassium difference across the hindleg during ketoacid infusion demonstrates that peripheral uptake of potassium is unlikely to be responsible for the observed hypokalemia. Although the tissue responsible for the different kalemic responses could not be defined with certainty, the data are compatible with an hepatic role in response to alterations in the portal vein insulin and/or glucagon levels in both acid infusion studies. We propose that cellular uptake of potassium is enhanced by hyperinsulinemia in ketoacid infusion, and release of potassium results from increased glucagon levels in HCl acidosis. Whether the changes in plasma potassium that other types od organic acid acidosis produce are accounted for by a similar hormonal mechanism remains to be determined.
H J Adrogué, Z Chap, T Ishida, J B Field
Title and authors | Publication | Year |
---|---|---|
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.
Rodgers RL |
Physiological Reports | 2022 |
The hepatic glucose-mobilizing effect of glucagon is not mediated by cyclic AMP most of the time
RL Rodgers |
American journal of physiology. Endocrinology and metabolism | 2021 |
Risk Factors for the Development of Hypokalemia in Neonatal Diarrheic Calves
FM Trefz, A Lorch, J Zitzl, A Kutschke, G Knubben-Schweizer, I Lorenz |
Journal of Veterinary Internal Medicine | 2015 |
Hyperkaliémie sévère ou menaçante : le diable est dans les détails
T Robert, V Algalarrondo, L Mesnard |
Réanimation | 2015 |
Alkalizing Nutritional Therapy in the Prevention and Reversal of any Cancerous Condition
RO Young |
2015 | |
Extracellular architecture of the SYG-1/SYG-2 adhesion complex instructs synaptogenesis.
Özkan E, Chia PH, Wang RR, Goriatcheva N, Borek D, Otwinowski Z, Walz T, Shen K, Garcia KC |
Cell | 2014 |
γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.
Aydintug MK, Zhang L, Wang C, Liang D, Wands JM, Michels AW, Hirsch B, Day BJ, Zhang G, Sun D, Eisenbarth GS, O'Brien RL, Born WK |
Molecular Immunology | 2014 |
Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity.
Dong Q, Giorgianni F, Deng X, Beranova-Giorgianni S, Bridges D, Park EA, Raghow R, Elam MB |
Biochemical and Biophysical Research Communications | 2014 |
Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects
Barua S, Mitragotri S |
Nano Today | 2014 |
The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Smith EP, An Z, Wagner C, Lewis AG, Cohen EB, Li B, Mahbod P, Sandoval D, Perez-Tilve D, Tamarina N, Philipson LH, Stoffers DA, Seeley RJ, D'Alessio DA |
Cell Metabolism | 2014 |
Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.
Chang PL, Hsieh YH, Wang CC, Juliana MM, Tsuruta Y, Timares L, Elmets C, Ho KJ |
Journal of Dermatological Science | 2014 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
Hyperkalemia in neonatal diarrheic calves depends on the degree of dehydration and the cause of the metabolic acidosis but does not require the presence of acidemia
FM Trefz, PD Constable, C Sauter-Louis, A Lorch, G Knubben-Schweizer, I Lorenz |
Journal of Dairy Science | 2013 |
Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
SP DiBartola, HA de Morais |
Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice | 2012 |
Differential diagnosis of hyperkalemia: an update to a complex problem
T Eleftheriadis, K Leivaditis, G Antoniadi, V Liakopoulos |
Hippokratia | 2012 |
Effects of pH on potassium: new explanations for old observations
PS Aronson, G Giebisch |
Journal of the American Society of Nephrology : JASN | 2011 |
Introduction to Acid-Base Disorders
SP DiBartola |
Fluid Electrolyte and Acid-Base Disorders in Small Animal Practice | 2006 |
Disorders of Potassium: Hypokalemia and Hyperkalemia
SP DiBartola, HA de Morais |
Fluid Electrolyte and Acid-Base Disorders in Small Animal Practice | 2006 |
Acid-Base Disorders and Their Treatment
L Hamm |
Acid-Base Disorders and Their Treatment | 2005 |
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry |
1997 | |
Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs
HJ Adrogué, J Peña, JP Comstock |
Metabolism | 1996 |
Hypoglycemia in Dialysis Patients
VO Rodriguez, R Arem, HJ Adrogué |
Seminars in Dialysis | 1995 |
Potassium and anaesthesia
JE Tetzlaff, JF OHara, MT Walsh |
Canadian Journal of Anesthesia/Journal canadien d'anesthésie | 1993 |
Glucose homeostasis and the kidney
HJ Adrogué |
Kidney International | 1992 |
Effect of acute acidosis and alkalosis on leucine kinetics in man
E Straumann, U Keller, D Kury, D Bloesch, A Thélin, MJ Arnaud, W Stauffacher |
Clinical Physiology | 1992 |
What determines the increase in liver cell volume in the fasted-to-fed transition: glycogen or insulin?
L Agius, M Peak, M al-Habori |
Biochemical Journal | 1991 |
Nephrology
M Hatano |
Nephrology | 1991 |
Hyperkalemia in Diabetic Ketoacidosis
M Fulop |
The American Journal of the Medical Sciences | 1990 |
Diabetic Ketoacidosis: A Practical Approach
HJ Adrogué, J Barrero, JE Ryan, GM Dolson |
Hospital Practice | 1989 |
Effect of acute reversal of experimentally-induced ketoacidosis with sodium bicarbonate on the plasma concentrations of phosphorus and potassium
JR Oster, HC Alpert, GR Rodriguez, CA Vaamonde |
Life Sciences | 1988 |
Acidosis-induced glucose intolerance is not prevented by adrenergic blockade
HJ Adrogue, Z Chap, Y Okuda, L Michael, C Hartley, M Entman, JB Field |
American journal of physiology. Endocrinology and metabolism | 1988 |
Diabetic Ketoacidosis: An Update
RA Kreisberg |
Critical Care Clinics | 1987 |
Diabetic ketoacidosis : current views on pathogenesis and treatment
U Keller |
Diabetologia | 1986 |
Lactic acidosis
NE Madias |
Kidney International | 1986 |
Extrarenal potassium homeostasis
RS Brown |
Kidney International | 1986 |
Glucose Counterregulation, Hypoglycemia, and Intensive Insulin Therapy in Diabetes Mellitus
FH Epstein, PE Cryer, JE Gerich |
New England Journal of Medicine | 1985 |
Therapy of Renal Diseases and Related Disorders
WN Suki, SG Massry |
1984 |